Upstream Manufacturing Webinars

  1. Inside The Technology Advancing CHO Therapeutic Protein Expression 9/18/2026

    Watch as Dr. Peter O'Callaghan, Senior Director and Head of Expression System Sciences, Licensing, answers key questions about the GS Gene Expression System® and the technologies behind its performance.

  2. Scaling AAV Manufacturing To 1000 L: Strategies For Robust Production 9/15/2026

    Learn how integrated cell line, media, and process design can support consistent AAV production at larger volumes while maintaining productivity and quality, as well as reducing scale-up risk.

  3. Driving Productivity Across The Antibody Manufacturing Workflow 9/14/2026

    Learn how integrated upstream and downstream strategies can reduce harvest bottlenecks, improve purification efficiency, and support scalable therapeutic antibody manufacturing.

  4. De-Risking Cell Culture Media Scale-Up For Late-Stage Manufacturing 9/11/2026

    Explore practical approaches to scaling cell culture media manufacturing, from supply assurance to evolving quality requirements, digital formulation tools, and strategies for controlling costs.

  5. Reducing Timelines And Development Costs Through Scale Up 9/11/2026

    See how an engineering-based approach to bioreactor scale-up delivered comparable cell growth, metabolic profiles, and product performance across cell lines and vessel sizes, helping reduce risks.

  6. Scaling AAV Purification: UF/DF Technologies That Deliver 9/11/2026

    Examine a data-driven comparison of hollow-fiber and flat-sheet TFF technologies for AAV manufacturing, covering process performance, scalability, engineering considerations, and cost.

  7. Accelerating A Promising Bispecific Antibody To The Clinic 9/9/2026

    See how an integrated perfusion and intensified fed-batch approach enabled rapid development of a sensitive protein process and successful clinical trial material production.

  8. Intensification Of Upstream Operations With Dynamic Perfusion 9/3/2026

    Dynamic perfusion simplifies continuous cell culture by eliminating cell bleed. Compare upstream strategies across productivity to understand their potential for more efficient mAb production.

  9. How Perfusion In Seed Train Bioreactors Can Simplify Upstream Processes 9/1/2026

    N-1 perfusion achieved approximately 95% viability while scaling from bench to production. See how this approach intensified seed trains without affecting subsequent fed-batch performance.

  10. Using Computational Fluid Dynamics To Design Scalable Processes 8/31/2026

    Learn how CFD modeling and experimental data can be combined to assess power input, mixing, oxygen transfer, and more across bioreactor scales, supporting sound process decisions.